QuantiFERON-TB Gold-Plus- Introduction, Test Parameters, Clinical Significance, and Keynotes

Introduction

QuantiFERON-TB Gold-Plus uses advanced technology to identify latent tuberculosis infection. Moreover, clinicians rely on it for precise detection of immune responses to TB antigens. In addition, this single-visit blood test minimizes patient inconvenience. However, doctors must verify active disease through clinical evaluation or imaging.

Therefore, they interpret test outcomes alongside a patient’s medical history. Furthermore, it helps avoid false positives from prior BCG vaccination.
Consequently, healthcare providers can reduce unnecessary follow-ups for borderline results. Ultimately, this test guides timely interventions that curtail tuberculosis transmission.

Test Parameters

This assay uses four specialized blood collection tubes. Each tube captures immune reactivity to Mycobacterium tuberculosis antigens. In addition, the Nil tube serves as a baseline control for background immune response. Furthermore, the Mitogen tube verifies immune competence as a positive control. Therefore, the TB1 and TB2 tubes measure cell-mediated responses from CD4+ and CD8+ T cells. Additionally, clinicians quantify interferon-gamma levels using an enzyme-linked immunosorbent assay (ELISA). Ultimately, specific cutoff values help distinguish latent TB infection from uninfected individuals.

Clinical Significance

This test helps identify latent TB infection in exposed individuals. In addition, it reduces false positives from prior BCG vaccination. Moreover, it provides a reliable alternative to the traditional Mantoux skin test. However, clinicians must correlate results with clinical and radiological findings.
Furthermore, the test assists in guiding prophylactic treatment decisions. Early detection prevents progression to active tuberculosis. Additionally, it supports public health initiatives by pinpointing high-risk groups. Hence, providers can focus resources on confirmed latent cases. Ultimately, it improves TB control and reduces transmission.

Keynotes

1. Firstly, this test detects latent TB infection via a single blood draw.
2. Moreover, it remains unaffected by previous BCG vaccination, reducing false positives.
3. In addition, healthcare providers measure interferon-gamma to evaluate immune reactivity.
4. However, doctors must correlate results with clinical evaluation and radiological findings.
5. Furthermore, the test’s four-tube system checks both CD4+ and CD8+ T cell responses.
6. Therefore, it offers reliable insights into an individual’s infection status.
7. Consequently, timely detection supports early prophylactic treatment.
8. Ultimately, it bolsters public health efforts against tuberculosis.

Further Readings

1. https://www.aafp.org/pubs/afp/issues/2021/0201/p177.html
2. https://quantiferon.com/jp/cd/patient-resources/quantiferon-tb-gold-2/
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC7269397/
4. https://www.lifelabs.com/test/quantiferon-tb-gold/
5. https://ltd.aruplab.com/Tests/Pub/3017554
6. https://int.diasorin.com/en/immunodiagnostics/infectious-diseases/liaison-quantiferon-tb-gold-plus
7. https://www.labcorp.com/tests/182879/quantiferon-tb-gold-plus
8. https://www.mayocliniclabs.com/test-catalog/overview/113563
9. https://testdirectory.questdiagnostics.com/test/test-detail/36970/quantiferon-tb-gold-plus-1-tube?cc=MASTER